| Biological Information | |
|---|---|
| Background Information: | This product is a companion product for use with KILR® cell lines and pools. These KILR® CD16 Effector Cells are purified human cytotoxic T lymphocytes stably expressing CD16, intended for use as effector cells in antibody-dependent cell-mediated cytotoxicity (ADCC) assays assessing cell death. The cells are produced in a standardized batch to allow for high levels of assay reproducibility. These purified effector cells are provided as five vials of cryopreserved cells. |
| Accession Number: | NC_000001.11 |
| Target Name: | CD16 |
| Target Aliases: | FcγRIII, CD16-II, CD16A, FCG3, FCGR3, FCGRIII, FCR-10, FCRIII, FCRIIIA, FcGRIIIA, IGFR3, IMD20 |
| Target Species: | Human |
| Usage | |
| Product Type: | Primary Cells |
| Application: | Cytotoxicity |
| Storage Conditions: | Short term (24 h): Store in vapor phase of liquid nitrogen. |
| Usage Disclaimer: | These products may be covered by issued US and/or foreign patents, patent application and subject to Limited Use Label License. Please visit discoverx.com/license for a list of products that are governed by limited use label license terms and relevant patent and trademark information. |
| Assay Information | |
| Assay Type: | Functional |
| Assay Measures: | Cytotoxicity |
| Detection Method: | Chemiluminescence |
| Clinical Relevance | |
| Therapeutic Area: | Oncology/Immuno-Oncology |
| Additional Information | |
| Brand: | KILR® |
KILR® CD16 Effector Cells
The KILR® CD16 Effector Cells are used with KILR® cell lines and pools to induce assayable cell death. These effector cells ship as five vials of cryopreserved primary cells.
User Manuals & Protocols
70-388 KILR CD16 Effector Cells UM_ REV7_final
View DocumentDatasheets
97-0007x Datasheet
View Document